Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951105 · ClinicalTrials.gov registry record · Phase 4
Effect of L-dopa In Subacute Back Pain Population
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT01951105 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 72 participants.
The verdict
NCT01951105, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study aims to determine if early treatment with Carbidopa/Levodopa and Naproxen in individuals with sub-acute back pain (SBP) is associated with changes in blocking transition to chronic back pain (CBP).
Interventions
- DRUG Placebo
- DRUG Naproxen
- DRUG Carbidopa/Levodopa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2015-02-24 |
| Est. Completion | 2017-09-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01951105
The ClinicalTrials.gov registry entry for NCT01951105 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01951105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01951105 about?
NCT01951105 is a clinical study titled "Effect of L-dopa In Subacute Back Pain Population". This study aims to determine if early treatment with Carbidopa/Levodopa and Naproxen in individuals with sub-acute back pain (SBP) is associated with changes in blocking transition to chronic back pain (CBP).
What is the current status of trial NCT01951105?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2015-02-24. Estimated completion is 2017-09-25.
What interventions are being tested in trial NCT01951105?
The interventions under investigation include: Placebo (DRUG), Naproxen (DRUG), Carbidopa/Levodopa (DRUG).
Who is sponsoring clinical trial NCT01951105?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.